Clik here to view.
Prestige Biopharma and Intas Pharmaceuticals Announce Partnership to...
SINGAPORE Prestige Biopharma Limited (KRX: 950210, hereafter referred to as “Prestige”) and Intas Pharmaceuticals Limited (hereafter referred to as “Intas”) today announced that the two companies...
View ArticleClik here to view.
Rapid Medical超小体积且唯一可调的取栓器获得FDA核准
以色列约克尼穆和多伦多 (美国商业资讯)–先进神经血管器械的领先开发商Rapid Medical在多伦多召开的神经介入外科学会(SNIS) 2022年第19届年会上宣布，TIGERTRIEVER™13已获得FDA 510(k)核准用于大血管闭塞。TIGERTRIEVER...
View ArticleClik here to view.
武田薬品工業：2022年度第1四半期は力強い業績を達成、通期マネジメントガイダンスの達成に向けて順調に進捗
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（TSE：4502/NYSE：TAK）は、本日、2022年度第1四半期の業績を公表しましたのでお知らせします。当第1四半期は力強い業績を達成し、通期マネジメントガイダンスの達成に向けて順調に進捗しています。...
View ArticleClik here to view.
Takeda Delivers Strong First Quarter FY2022 Results; On Track Towards...
OSAKA, Japan Takeda (TOKYO:4502/NYSE:TAK) today announced strong financial results for the first quarter of fiscal year 2022 (period ended June 30, 2022) and is on track to meet its full-year...
View ArticleClik here to view.
PCIファーマ・サービシズが、がん治療薬をサポートする高薬理活性物質の世界的製造サービスに対する需要拡大に対応すべく、数百万ドルを投じた英国製造施設の拡張を発表
フィラデルフィア （ビジネスワイヤ） — 世界一流の医薬品開発製造受託機関（CDMO）であるPCIファーマ・サービシズ（PCI）は本日、強力ながん標的治療薬の市場成長に迅速対応できるよう、英国ウェールズのトレデガーにある世界クラスの当社施設を大幅に拡張すると発表しました。...
View ArticleClik here to view.
PCI Pharma Services宣布斥资数百万美元扩建英国制造设施，以满足市场对支持肿瘤治疗的全球高效药制造服务日益增长的需求
费城 (美国商业资讯)–全球领先的合同开发与制造组织(CDMO) PCI Pharma Services (PCI)今天宣布，公司对位于英国威尔士特雷迪加(Tredegar)的世界级工厂进行重大扩建，旨在跟上强效靶向肿瘤疗法的市场增长速度。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Dr. Reddy’s Laboratories enters into a licensing agreement with Slayback...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today...
View ArticleClik here to view.
武田公司2022财年第一季度业绩强劲；正稳步实现全年的管理层指引目标
日本大阪 (美国商业资讯)–武田(Takeda, TOKYO:4502/NYSE:TAK)今天公布了2022财年第一季度（截至2022年6月30日）的强劲财务业绩，正稳步实现其全年的管理层指引目标。...
View ArticleClik here to view.
InnoCare Announces First Subject Dosed in Clinical Trial of TYK2 JH2...
BEIJING InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first subject has been dosed in...
View ArticleClik here to view.
Finalization of Vifor Pharma acquisition
MELBOURNE, Australia & ST. GALLEN, Switzerland Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220801005796/en/ AD...
View ArticleClik here to view.
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for...
GUANGZHOU, China Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase 1 clinical study evaluating BAT8009, an antibody...
View ArticleClik here to view.
Adalvo Acquires Its First Branded Product, Onsolis®
MSIDA, Malta The global pharmaceutical company Adalvo today announced the acquisition of its first branded product, Onsolis® after concluding a deal with a reputable US based specialty...
View ArticleClik here to view.
PharmaEssentia Appoints Dr. Lih-Ling Lin as Chief Scientific Officer
BURLINGTON, Mass. PharmaEssentia Corporation, (TPEx:6446), a global biopharmaceutical innovator leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and...
View ArticleClik here to view.
OliX Pharmaceuticals Receives IND Approval from FDA to Develop RNAi...
SUWON, South Korea OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s...
View ArticleClik here to view.
Shape Memory Medical Celebrates Treatment of 1,500th Patient
SANTA CLARA, Calif. Shape Memory Medical Inc., developer of shape memory polymer devices for peripheral and neurovascular markets, announced today that its 1,500th patient has been treated, marking...
View ArticleClik here to view.
Adalvo收购其首个品牌产品Onsolis®
马耳他姆西达 (美国商业资讯)–全球制药公司Adalvo今天宣布，该公司与一家声誉良好的美国专业制药公司达成交易，收购了其首个品牌产品Onsolis®。这家美国制药公司是该产品的原始拥有者。...
View ArticleClik here to view.
World’s First Discovery of Scallop-derived Plasmalogens Enhancing Antiviral...
FUKUOKA, Japan The Japanese Plasmalogen Society (Office: Higashi-ku, Fukuoka, Japan; President: Yutaka Oomura) announced the research results that scallop-derived plasmalogens enhanced antiviral...
View ArticleClik here to view.
GenomOncology和Congenica宣布合作开发新型精准肿瘤学解决方案
英格兰剑桥 (美国商业资讯)–Congenica是一家总部位于英国的数字健康公司，致力于实现基因组数据的快速分析与解读。该公司已选择GenomOncology的精准肿瘤学平台来开发一种新颖的突破性CE-IVD精准肿瘤学解决方案。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20220803005524/zh-CN/...
View ArticleClik here to view.
BioDuro-Sundia and X-Chem Enter Partnership to Launch DEL Services in China...
SHANGHAI BioDuro-Sundia, an industry-leading drug discovery, development and commercial service CRDMO backed by Advent International, and X-Chem, a DEL technology pioneer in small molecule drug...
View ArticleClik here to view.
ゲノムオンコロジーとコンジェニカが新規精密オンコロジーソリューションの共同開発を発表
英ケンブリッジ （ビジネスワイヤ） — ゲノムデータの迅速な解析と解釈を実現する英国のデジタルヘルス企業であるコンジェニカは、画期的な新規CE-IVD精密オンコロジーソリューションの開発にゲノムオンコロジーの精密オンコロジープラットフォームを採用しました。...
View Article